Abstract graphic of an eye
Investor Relations

Press Release

HBIO President David Green to Present January 19, 2010 at Global Investor Day 2010

January 12, 2010

HOLLISTON, Mass., Jan. 12, 2010 (GLOBE NEWSWIRE) -- Harvard Bioscience, Inc. (Nasdaq:HBIO), a global developer, manufacturer and marketer of a broad range of specialized products used to advance life science research, today announced that its President, David Green, will present on January 19, 2010 from 9:00 a.m. - 9:30 a.m. EST at Global Investor Day 2010.

The presentation will be accessible on January 19, 2010 by visiting http://www.globalinvestorday.com, opening the "Healthcare & Pharmaceuticals" sector and following the registration instructions to attend the conference. The Harvard Bioscience presentation will be archived on this site for 30 days. The presentation will cover the historical and expected future performance of the business. Some of the information to be presented by Mr. Green may contain information that has not previously been disclosed. Additionally, any material financial or other statistical information presented in our presentation, which has not been previously disclosed will be archived and available in the Investor Relations section of our website.

About Harvard Bioscience

Harvard Bioscience ("HBIO") is a global developer, manufacturer and marketer of a broad range of specialized products, primarily scientific instruments and apparatus, used to advance life science research at pharmaceutical and biotechnology companies, universities and government laboratories worldwide. HBIO sells its products to thousands of researchers in over 100 countries primarily through its 900 page catalog (and various other specialty catalogs), its website and through its distributors, including GE Healthcare, Thermo Fisher Scientific and VWR. HBIO has sales and manufacturing operations in the United States, the United Kingdom, Germany and Spain with additional facilities in France and Canada. For more information, please visit www.harvardbioscience.com.

For investor inquiries, please call (508) 893-8066. Press releases may be found on our web site, http://www.harvardbioscience.com.

The Harvard Bioscience, Inc. logo is available at http://www.globenewswire.com/newsroom/prs/?pkgid=6426

CONTACT:  Harvard Bioscience, Inc.
          David Green, President
            508 893 8999
            Fax: 508 429 8478
            dgreen@harvardbioscience.com
          Chane Graziano, CEO
            cgraziano@harvardbioscience.com
          Tom McNaughton, CFO
            tmcnaughton@harvardbioscience.com

(C) Copyright 2010 GlobeNewswire, Inc. All rights reserved.